Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (11920)	12/1/1997 2:01:00 PM
From: Andrew H	Read Replies (1) \| Respond to of 32384

Nic to have you back and posting Henry. How did the Strikers do? WLA is now down 26 according to Yahoo--hard to believe. LLY however is up 2 and Lgnd is up as well (Hallelujah!). While it would be a huge problem for diabetes sufferers if Rezulin should be pulled from the market (highly unlikely), it would be a big plus for LLY and LGND. But WLA down 26 is a tremendous over reaction. Just shows what LGND and LLY might do if positive P2 clinicals on Targretin trials were released.